METHSCOPOLAMINE BROMIDE
- Product NDC
- 76385-101
- 11-digit product format
- 763850101
- Labeler code
- 76385
- Product ID
- 76385-101_10a9a368-4ddc-4ffc-abfb-605c98fe1d97
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methscopolamine bromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unichem Pharmaceuticals (USA), Inc.
- Application
- ANDA200602
- Marketing category
- ANDA
- Marketing start
- 2013-10-01
- Substance
- METHSCOPOLAMINE BROMIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200602-001 | METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | |
| A200602-002 | METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A200602-001 | AA |
| A200602-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | AA | 2012-09-24 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | AA | RS | 2012-09-24 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A200602-001 | METHSCOPOLAMINE BROMIDE | 2.5MG | TABLET / ORAL | 2012-09-24 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A200602-002 | METHSCOPOLAMINE BROMIDE | 5MG | TABLET / ORAL | RS | 2012-09-24 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A200602-001 | AA | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A200602-002 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A200602-001 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A200602-002 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A200602-001 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200602-002 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200602-001 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200602-002 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A200602-001 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200602-002 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200602-001 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200602-002 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200602-001 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200602-002 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200602-001 | AA | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200602-002 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200602-001 | AA | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200602-002 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200602-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200602-002 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200602-001 | AA | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200602-002 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A200602-001 | AA | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A200602-002 | AA | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200602-001 | AA | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200602-002 | AA | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200602-001 | AA | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200602-002 | AA | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200602-001 | AA | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200602-002 | AA | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A200602-001 | AA | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A200602-002 | AA | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200602-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200602-002 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A200602-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A200602-002 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A200602-001 | AA | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A200602-002 | AA | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A200602-001 | AA | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A200602-002 | AA | 1 | bb7c543d1eb4… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- METHSCOPOLAMINE BROMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METHSCOPOLAMINE BROMIDE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| RTN51LK7WL | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5c74bfb0-c80a-4a86-acd1-1e3a1b20255d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 62bf66cd-09d0-4b08-aa9d-7b67e1476683 | Product name | 2 | 20250114 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76385-101-60 | METHSCOPOLAMINE BROMIDE | 60 in 1 BOTTLE | TABLET | 60 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76385-101-60 | EA - Each | 76385-101 | 8662f159-b793-4247-ad62-e23925905aae | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHSCOPOLAMINE BROMIDE | ACTIVE INGREDIENT | RTN51LK7WL | METHSCOPOLAMINE BROMIDE TABLET [BAYSHORE PHARMACEUTICALS LLC] | 2 | |
| METHSCOPOLAMINE | ACTIVE MOIETY | VDR09VTQ8U | METHSCOPOLAMINE BROMIDE TABLET [BAYSHORE PHARMACEUTICALS LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | METHSCOPOLAMINE BROMIDE TABLET [BAYSHORE PHARMACEUTICALS LLC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | METHSCOPOLAMINE BROMIDE TABLET [BAYSHORE PHARMACEUTICALS LLC] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | METHSCOPOLAMINE BROMIDE TABLET [BAYSHORE PHARMACEUTICALS LLC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | METHSCOPOLAMINE BROMIDE TABLET [BAYSHORE PHARMACEUTICALS LLC] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | Bryant Ranch Prepack | 4ee28ed4-daff-462c-a38b-4fd8250ed9f4 | 2026-06-30 | Warnings, Adverse reactions | 200602 ANDA200602 |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | Bryant Ranch Prepack | 6b8ed187-d378-4c95-80e0-0d3558a7aa95 | 2026-03-13 | Warnings, Adverse reactions | 200602 ANDA200602 |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | PD-Rx Pharmaceuticals, Inc. | 26cd56db-4727-40d1-8f08-3ee899052c77 | 2026-01-05 | Warnings, Adverse reactions | 200602 ANDA200602 |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | PD-Rx Pharmaceuticals, Inc. | 8a14ade6-d428-4144-9037-46955f68820f | 2026-01-05 | Warnings, Adverse reactions | 200602 ANDA200602 |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | Unichem Pharmaceuticals (USA), Inc. | 5c74bfb0-c80a-4a86-acd1-1e3a1b20255d | 2025-12-10 | Warnings, Adverse reactions | 200602 ANDA200602 76385-101 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 403914 | methscopolamine bromide 5 MG Oral Tablet | PSN | 6b8ed187-d378-4c95-80e0-0d3558a7aa95 | 101 |
| 403914 | methscopolamine bromide 5 MG Oral Tablet | SCD | 6b8ed187-d378-4c95-80e0-0d3558a7aa95 | 101 |
| 403914 | methscopolamine bromide 5 MG Oral Tablet | PSN | 8a14ade6-d428-4144-9037-46955f68820f | 11 |
| 403914 | methscopolamine bromide 5 MG Oral Tablet | SCD | 8a14ade6-d428-4144-9037-46955f68820f | 11 |
| 314088 | methscopolamine bromide 2.5 MG Oral Tablet | PSN | 5c74bfb0-c80a-4a86-acd1-1e3a1b20255d | 9 |
| 403914 | methscopolamine bromide 5 MG Oral Tablet | PSN | 5c74bfb0-c80a-4a86-acd1-1e3a1b20255d | 9 |
| 314088 | methscopolamine bromide 2.5 MG Oral Tablet | SCD | 5c74bfb0-c80a-4a86-acd1-1e3a1b20255d | 9 |
| 403914 | methscopolamine bromide 5 MG Oral Tablet | SCD | 5c74bfb0-c80a-4a86-acd1-1e3a1b20255d | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 76385-101-60 | 76385010160 | 60 TABLET in 1 BOTTLE (76385-101-60) | 60 tablet | 2013-10-01 | 0000-00-00 | No | No | Current |